RGT 3.03% 32.0¢ argent biopharma limited

Ann: Appendix 3Y - Change of Director's Interest Notice x 3, page-28

  1. 327 Posts.
    lightbulb Created with Sketch. 94
    My understanding is that "performamce rights" can be converted at anytime. There is no consideration to be paid. Seems the only real justification is lasting the distance, and getting an "intrim" GMP certification, so why now? Still no deposit, still no actual revenue only speculation about revenue expectations, assuming everything falls into place. Makes you wonder in who's interest the directors are really working in. Its always been one of my reservations about this company.
    The only positive I can see is that there must be some good news coming up for the management and staff to sell into. Would not be surprised to see another CR in the near future and a share consolidation after June 2019.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.010(3.03%)
Mkt cap ! $15.48M
Open High Low Value Volume
34.0¢ 34.0¢ 32.0¢ $6.532K 19.88K

Buyers (Bids)

No. Vol. Price($)
1 15000 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 5000 1
View Market Depth
Last trade - 14.37pm 04/09/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.